Chimeric Antigen Receptor T Cell Therapy (CAR-T): Genetically programmed immune cell binds to and destroys cancer cell / Therapy is now available for the majority of indications
27. January 2023 • News
27. January 2023 • News
As a renter, you want a flexible setup and good neighbors. That’s why future life science industry tenants of CCL CityLab Leipzig can count themselves lucky: Each floor of the 5-story building (total floorspace: ~7,000 m2) can be individually tailored according to the working environment which is needed, whether laboratory unit or office space. And with the Fraunhofer and Max Planck Institutes, BioCity and BioCube, as well as the University of Leipzig in close proximity, companies who choose CityLab Leipzig will find themselves at the epicenter of the city’s life science and biotech ecosystem. Construction has already begun and will proceed in two phases, with the first unit scheduled to be completed in the fall of 2023. Interested? Feel free to find out more.
For more details, please go to vollack.de/en/projects/cll-citylab-leipzig
Chimeric Antigen Receptor T Cell Therapy (CAR-T): Genetically programmed immune cell binds to and destroys cancer cell / Therapy is now available for the majority of indications
The Smart Infrastructure Hub Leipzig will receive a further 1,9 million euros from the cluster funding of the Saxon Ministry of Economic Affairs.
A relatively small metropolis in Germany’s Free State of Saxony – a dynamic hub for the life science industry? What was just a vision 20 years ago has become a reality for the city of Leipzig, which from October 24-26 co-hosted BIO-Europe, Europe’s largest annual biotech partnering event.
The European Commission has approved the Saxon ERDF/JTF program for the funding period 2021 to 2027.